Pages that link to "Q53242223"
Jump to navigation
Jump to search
The following pages link to Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. (Q53242223):
Displaying 50 items.
- Economic evaluation of pneumococcal conjugate vaccination in The Gambia (Q21261836) (← links)
- A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells (Q24651147) (← links)
- Comparison of impact and cost-effectiveness of rotavirus supplementary and routine immunization in a complex humanitarian emergency, Somali case study (Q28257258) (← links)
- Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique (Q28475795) (← links)
- Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria (Q28542985) (← links)
- Meeting oxygen needs in Africa: an options analysis from the Gambia (Q28751034) (← links)
- The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries (Q33373915) (← links)
- Overview of the disease burden of invasive pneumococcal disease in Asia (Q33435016) (← links)
- Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study (Q33452537) (← links)
- Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells (Q33521821) (← links)
- Cost-effectiveness of pre-referral antimalarial, antibacterial, and combined rectal formulations for severe febrile illness (Q33785764) (← links)
- Does spending on refugees make a difference? A cross-sectional study of the association between refugee program spending and health outcomes in 70 sites in 17 countries. (Q33816630) (← links)
- Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (Q33898827) (← links)
- Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden (Q33934529) (← links)
- WHO policy development processes for a new vaccine: case study of malaria vaccines (Q34008911) (← links)
- Antibiotic Use in Thailand: Quantifying Impact on Blood Culture Yield and Estimates of Pneumococcal Bacteremia Incidence (Q34024818) (← links)
- Evaluating investments in typhoid vaccines in two slums in Kolkata, India (Q34083583) (← links)
- Oxygen is an essential medicine: a call for international action (Q34284818) (← links)
- The role of health systems and policy in producing behavior and social change to enhance child survival and development in low- and middle-income countries: an examination of the evidence (Q34385334) (← links)
- Reductions in inpatient mortality following interventions to improve emergency hospital care in Freetown, Sierra Leone (Q34426708) (← links)
- Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model (Q34471089) (← links)
- Variations in mortality in children admitted with pneumonia to Kenyan hospitals (Q34471839) (← links)
- Assessment of health benefits and cost-effectiveness of 10-valent and 13-valent pneumococcal conjugate vaccination in Kenyan children (Q34796940) (← links)
- Improved oxygen systems for childhood pneumonia: a multihospital effectiveness study in Papua New Guinea (Q34809656) (← links)
- Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination (Q35089126) (← links)
- Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa (Q35973769) (← links)
- Cost-effectiveness of essential newborn care training in urban first-level facilities (Q36071116) (← links)
- Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008 (Q36276795) (← links)
- The use of cost-effectiveness analysis for pediatric immunization in developing countries (Q36490234) (← links)
- The economic burden of childhood pneumococcal diseases in The Gambia (Q36591935) (← links)
- The preventable burden of pneumococcal disease in the developing world (Q36617624) (← links)
- The contribution of immunology to the rational design of novel antibacterial vaccines (Q36844711) (← links)
- Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? (Q36914109) (← links)
- Preventing bacterial disease in the HIV-infected of sub-Saharan Africa: the role of cotrimoxazole and the pneumococcal vaccines (Q36947463) (← links)
- The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease (Q36987446) (← links)
- Disability and disability-adjusted life years: not the same. (Q37106429) (← links)
- Vaccines to prevent pneumonia and improve child survival (Q37108802) (← links)
- Transmission of Streptococcus pneumoniae in an urban slum community (Q37124714) (← links)
- Comparative impact assessment of child pneumonia interventions (Q37202026) (← links)
- Prospects for use of interleukin-12 as a mucosal adjuvant for vaccination of humans to protect against respiratory pneumococcal infection. (Q37207581) (← links)
- Economic impact of a rotavirus vaccine in Brazil (Q37339643) (← links)
- Cost-effectiveness of 13-valent pneumococcal conjugate vaccination in Mongolia (Q37631215) (← links)
- Pneumococcal conjugate vaccine: review of cost-effectiveness studies in Australia, North America and Europe (Q37763127) (← links)
- Evidence-based decision making for vaccines: The need for an ethical foundation (Q37971231) (← links)
- Immunization of newborns with bacterial conjugate vaccines (Q38021240) (← links)
- Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review (Q38059027) (← links)
- Systematic review of incremental non-vaccine cost estimates used in cost-effectiveness analysis on the introduction of rotavirus and pneumococcal vaccines. (Q38115373) (← links)
- CPAP: a guide for clinicians in developing countries (Q38155962) (← links)
- Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014). (Q38355461) (← links)
- Estimating costs of care for meningitis infections in low- and middle-income countries (Q38445981) (← links)